ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
62,817.03
-0.37%
S&P 500
5,214.08
0.51%
Dow Jones
39,387.76
0.85%
US Dollar vs Yen
155.705
0.20%
Brent Oil
84.115
0.20%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. USOTC
  6. Pharming Group NV Leiden (PK) (PHGUF)

  7. Pharming Group NV Leiden (PK) (PHGUF) ニュース

PHGUF

Pharming Group NV Leiden (PK) (PHGUF)

Pharming Group NV Leiden (PK)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:PHGUF
日付受信時刻ニュースソース見出しコード企業名
2023/12/1520 : 04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
2023/11/1323 : 59Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
2023/09/2523 : 20Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
2023/08/1421 : 31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
2023/08/1000 : 24Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
2023/07/1819 : 40Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PHGUFPharming Group NV Leiden (PK)
2023/06/0119 : 15Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
2023/04/1121 : 58Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
2023/04/0519 : 57Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:PHGUFPharming Group NV Leiden (PK)
2023/03/2802 : 41Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
2023/03/1623 : 39Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
2023/03/1320 : 34Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
2023/03/1320 : 01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
2023/02/2123 : 43Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
2023/02/1800 : 41Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
2022/10/2719 : 29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
2022/08/0219 : 09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
2022/06/0221 : 32Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
2022/05/1901 : 55Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
2022/04/2620 : 07Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
2022/04/0705 : 15Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:PHGUFPharming Group NV Leiden (PK)
2022/04/0705 : 10Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
2022/01/0621 : 03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
2022/01/0421 : 03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
2021/10/2905 : 18Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:PHGUFPharming Group NV Leiden (PK)
2021/10/2820 : 04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
2021/10/2220 : 02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
2021/09/1422 : 00Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
2021/08/1005 : 05Edgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)USOTC:PHGUFPharming Group NV Leiden (PK)
2021/08/0520 : 01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PHGUFPharming Group NV Leiden (PK)
 Showing the most relevant articles for your search:USOTC:PHGUF

最近閲覧した銘柄

USOTC
DTEGY
Deutsche Telekom (QX)
FX
USDGBP
US Dollar vs Sterling
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
BASFY
BASF (QX)
NYSE
XOM
Exxon Mobil
USI
USTECH100
US Tech 100
NYSE
JPM
JP Morgan Chase
FX
USDJPY
US Dollar vs Yen
COIN
SOLUSD
Solana
CCOM
US500
US 500
NYSE
MCD
McDonalds
USOTC
RHHBY
Roche (QX)
AMEX
SPY
SPDR S&P 500
NYSE
VZ
Verizon Communications
COIN
ETHUSD
Ethereum
PM
XAUUSD
Gold vs US Dollar
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有